Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Dedicated to enhancing knowledge and skill in the care of the allergic patient."

ADVOCACY UPDATES

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

04/01/20: Fellow Exam Application Deadline
Learn more

06/01/20: Call for Scientific Papers
Coming Soon

06/01/20: Research Grant Cycle
Learn more

06/26/20: Membership Application Deadline to be eligible for AAOA Member rate for the 2020 Basic Course Learn more

09/11/20: Membership Application Deadline to be voted in at the 2020 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2020 Annual Meeting Learn more

12/01/20: Research Grant Cycle
Learn more

EDUCATION

Here is What You Missed...

2019 New Orleans was an outstanding success?  With over 500 participants, our AAOA members left New Orleans re-energized, re-freshed, and re-engaged.  The program offered something for everyone — from cutting edge clinical content to every day how to’s for practice management efficiencies. Read More

IFAR

IFAR Impact Factor: 2.454

aaoaf-ifar

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2020 Basic Course in Allergy & Immunology
July 9-11 | Orlando, FL
Learn More and Register

2020 AAOA Annual Meeting
October 23-25| Scottsdale, AZ
Learn More and Register

2020 Advanced Course in Allergy & Immunology
December 9-12 | Vail, CO
Learn More and Register

AAOA Clinical Insights
Learn More and Register

NEW!!! USP 797 Online Module
Learn More and Register

News and Updates

Socio-Economic Committee Update May 2017

By AAOA Leadership Change is the only constant in life and medicine to borrow from…

read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PATIENT CORNER

Off to College: Tips for Managing Allergies

Heading to college is an exciting time. What are the best ways for students to avoid exacerbation of their symptoms as they enter the hallowed halls of higher learning?

Read More

Menu

Health Policy Updates tied to COVID-19

HILL UPDATES

  • Senate Republicans released an updated version of the CARES Act on Sunday, March 22nd.  The amended package is estimated at $1.8 trillion, with the text available here. The funding provisions are included in Division B, which is available here. The updated summary from Senate Republicans is here.  
    • After two failed procedural votes on Sunday evening and Monday afternoon, negotiations continued through Monday on a bill that could gain the 60 votes needed to pass the procedural hurdle. Majority Leader McConnell said that a vote may not occur until Friday or Saturday.
  • On the other side of the Capitol, Speaker Pelosi released a separate version of the phase 3 stimulus package in the House earlier on Monday, the Take Responsibility for Workers and Families Act.  The bill provides additional appropriations funding for each of the 12 appropriations bills, including Labor, Health and Human Services appropriations.  The bill also includes provisions related to paid sick leave, protecting the health care workforce and related economic provisions.  We are providing summaries of a few key health care items below, and we will send a link to the updated bill text when we receive it.
    • Coverage of Testing and Treatment: the bill would extend coverage of COVID-19 testing and treatment for Medicaid, Medicare and private health insurance plans. It also provides optional coverage for uninsured individuals under Medicaid.
    • Other Health Care Provisions:
      • Extends funding for Community Health Centers, the National Health Service Corps, Teaching Centers that Operate GME Programs, the Special Diabetes Program and the Special Diabetes Program for Indians through November 30, 2020. This is a change from the Senate version that provided for a two-year extension.
      • Requires Part D plans to allow beneficiaries to obtain up to three-month supply of their Part D prescription drugs during the COVID-19 public health emergency. 
      • Clarifies coverage requirements for in vitro diagnostic tests in compliance with the Food and Drug Administration’s (FDA) guidance on diagnostic tests for COVID-19 during a public health emergency.
      • Includes a Sense of Congress that during the COVID-19 pandemic health care providers should refrain from balance billing consumers for out-of-network claims related to COVID-19 testing or treatment, and insurance companies should do their utmost to secure access to in-network treatment for their plan participants.
      • Allows for the National Disaster Medical System to reimburse for the cost of COVID-19 treatment expenses.
      • Provides additional support for public health data and surveillance systems, as well as the public health workforce.
      • Establishes a loan program to help eligible health care organizations with anticipated revenue loss or higher operating costs as a result of COVID-19. 
  • Today Senators Chris Murphy (D-CT) and Brian Schatz (D-HI) introduced the “Medical Supply Chain Emergency Act” that would force implementation of the Defense Production Act (DPA) of 1950. The bill would require the President to use authorities under the DPA to require emergency production of medical equipment to address the COVID-19 outbreak. Learn more here.  A House companion bill is expected to be introduced in the coming days.

ADMINISTRATION UPDATES

  • CMS released COVID-19 checklists and toolkits for state Medicaid and CHIP programs to help speed states’ access to emergency flexibilities and resources. A link to these resources can be found here: https://www.cms.gov/newsroom/press-releases/trump-administration-releases-covid-19-checklists-and-tools-accelerate-relief-state-medicaid-chip.
  • On March 22nd, CMS announced it is granting exceptions from reporting requirements and extensions for clinicians participating in Medicare quality reporting programs for upcoming measure reporting and data submission.  More details can be found here: https://www.cms.gov/newsroom/press-releases/cms-announces-relief-clinicians-providers-hospitals-and-facilities-participating-quality-reporting.
    • Provider Programs:
      • ESRD Quality Incentive Program: 2019 Q4 data submission is optional. CMS will not count data from January 1, 2020 through June 30, 2020.
      • Quality Payment Program and the Medicare Shared Savings Program: 2019 data submission deadline is extended by a month until April 30, 2020. Providers who don’t report by April 30 will qualify for the automatic extreme and uncontrollable circumstances policy and will receive a neutral payment adjustment for the 2021 MIPS payment year.  Options for the 2020 performance year are still being evaluated.
    • Hospital Programs:
      • ASC Quality Reporting Program: deadlines for October 1, 2019 to December 1, 2019 (Q4) data submission is optional. Data does not need to be submitted for January 1, 2020 to June 30, 2020.